diagnostics

For Eisai and Biogen's Leqembi, first FDA-approved Alzheimer's blood test will take time to boost launch: analyst
Fierce Pharma
Mon, 05/19/25 - 10:25 pm
Eisai
Biogen
Alzheimer's disease
Leqembi
diagnostics
Regeneron wins bid to buy 23andMe out of bankruptcy
BioPharma Dive
Mon, 05/19/25 - 11:29 am
Regeneron
23andMe
M&A
Medtech
diagnostics
genetic testing
FDA clears its first blood test for diagnosing Alzheimer's disease, with Fujirebio's Lumipulse
Fierce Biotech
Sun, 05/18/25 - 10:38 pm
Fujirebio Diagnostics
FDA
Alzheimer's disease
diagnostics
Lumipulse G
Elizabeth Holmes’s partner reportedly raises millions for blood-testing startup
The Guardian, UK
Tue, 05/13/25 - 11:24 am
Elizabeth Holmes
Theranos
diagnostics
funding
Haemanthus
Billy Evans
A judge blocked the FDA’s plan to regulate LDTs. What now?
Medtech Dive
Wed, 04/16/25 - 11:16 am
Medtech
LDTs
FDA
legal
diagnostics
Texas judge overturns FDA’s lab developed test regulation, siding with industry groups
Medtech Dive
Wed, 04/2/25 - 11:26 am
Texas
legal
lab-developed tests
Medtech
FDA
diagnostics
FTC concerned about privacy protections in 23andMe bankruptcy
Yahoo/Reuters
Tue, 04/1/25 - 11:37 am
23andMe
diagnostics
FDC
data
bankruptcy
A Drop of Blood, A Wealth of Information: New At-Home A1C Testing
Medical Devices and Diagnostics Industry
Wed, 03/26/25 - 10:21 am
Medtech
diagnostics
diabetes
HbA1C
at-home testing
Orange Biomed
23andMe files for bankruptcy, Anne Wojcicki steps down as CEO
CNBC
Mon, 03/24/25 - 11:18 am
23andMe
bankruptcy
Anne Wojcicki
Medtech
diagnostics
Elypta’s urine test identifies 90% of recurrent kidney cancer cases
Clinical Trials Arena
Mon, 03/24/25 - 11:03 am
Elypta
diagnostics
kidney cancer
Labcorp is buying Bioreference health’s cancer testing business for $192m
MedCity News
Sun, 03/16/25 - 09:52 pm
Medtech
diagnostics
M&A
LabCorp
BioReference Labs
cancer
Quest to buy Fresenius Medical Care kidney testing assets
Medtech Dive
Wed, 02/26/25 - 11:09 am
Quest Diagnostics
M&A
Fresenius Medical Care
diagnostics
kidney disease
Medtech
Hims & Hers to offer at-home blood draws and lab testing with new acquisition
CNBC
Thu, 02/20/25 - 11:25 am
Hims & Hers Health
M&A
Trybe Labs
diagnostics
Medtech
Becton looks to separate biosciences and diagnostic solutions after upbeat quarterly results
Yahoo/Reuters
Fri, 02/7/25 - 11:29 am
Medtech
Becton Dickinson
earnings
diagnostics
Teladoc Health acquires Catapult Health for $65M to boost chronic condition management, at-home testing
Fierce Healthcare
Wed, 02/5/25 - 10:45 pm
Teladoc Health
Catapult Health
telehealth
diagnostics
M&A
Troubled 23andMe is exploring a sale of the business
Pharmaphorum
Wed, 01/29/25 - 11:12 am
23andMe
M&A
Medtech
diagnostics
Geneoscopy Prepares Launch of FDA-approved At-home RNA Colorectal Cancer Screening Test
Medical Devices and Diagnostics Industry
Tue, 01/21/25 - 11:06 am
Medtech
diagnostics
Geneoscopy
RNA
Colosense
colorectal cancer
Qiagen Receives FDA Clearance for First Mini Gastrointestinal Panel
Xtalks
Thu, 01/16/25 - 11:15 am
Qiagen
Medtech
diagnostics
FDA
gastrointestinal disease
Exact Sciences showcases early cancer detection test data at AACR meeting
Clinical Trials Arena
Fri, 11/15/24 - 11:13 am
Medtech
diagnostics
EXACT Sciences
biomarkers
cancer
MCED
AACR
23andMe Cuts 40% of Its Workforce, Discontinues All Therapy Programs
US News and World Report
Mon, 11/11/24 - 06:36 pm
23andMe
Medtech
diagnostics
layoffs

Pages